Best in Biotech 17 Dec 2025 Eight of the biggest immunology and inflammation (I&I) deals in 2025 Discover eight of the biggest immunology and inflammation (I&I) deals in 2025, from early-stage collaborations to late-stage licensing deals. December 17, 2025 - 9 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email
Best in Biotech 15 Dec 2025 Keep an eye on these 15 biotech companies in 2026 Some companies have had wins in 2025, while others have major milestones coming up. Here are 15 biotechs to watch as we head into 2026. December 15, 2025 - 21 minutesmins - Multiple Authors Share WhatsApp Twitter Linkedin Email
In Depth 10 Dec 2025 Promising cure for COPD: Is a breakthrough treatment within reach? Find out whether a promising cure for COPD is within reach, after recent advancements in treatments and research around the disease. December 10, 2025 - 12 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email
In Depth 5 Dec 2025 The biggest biotech funding rounds in November 2025 The companies Cogent Biosciences, Braveheart Bio, and AAVantgarde bagged the biggest biotech funding rounds overall in November 2025. December 5, 2025 - 4 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email
In Depth 3 Dec 2025 Boehringer Ingelheim’s pipeline activity: A busy year of dealmaking for the German pharma in 2025 Discover Boehringer Ingelheim’s pipeline focus areas and how its dealmaking in 2025 has expanded its therapeutic arsenal. December 3, 2025 - 11 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email
In Depth 28 Nov 2025 Research Triangle Park: A closer look at North Carolina’s burgeoning biotech hub Discover what makes North Carolina’s Research Triangle Park’s life sciences and biotech ecosystem so successful. November 28, 2025 - 6 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email
Best in Biotech 25 Nov 2025 11 neuroscience biotech companies you should know about Learn more about 11 of the top neuroscience biotech companies looking to develop treatments for difficult-to-treat neurological conditions. November 25, 2025 - 16 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email
Best in Biotech 21 Nov 2025 Six key obesity deals in 2025 Discover six obesity deals made so far in 2025, with dealmaking activity in the field being largely dominated by big pharma companies. November 21, 2025 - 8 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email
In Depth 18 Nov 2025 Twice the punch: The emergence of dual-payload antibody and peptide drug conjugates Discover the emergence of dual-payload ADCs and PDCs, which could mark a significant evolution in targeted therapeutics. November 18, 2025 - 8 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email
Best in Biotech 14 Nov 2025 10 gene therapy companies you should know about Explore 10 gene therapy companies operating within the biotech industry, as each one hopes to develop their own novel candidates. November 14, 2025 - 15 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email
In Depth 5 Nov 2025 Novo Nordisk’s pipeline plan: How the pharma giant is refocusing amid major restructuring Discover how Novo Nordisk’s pipeline is being restructured to refocus its efforts on high-growth areas like diabetes and obesity. November 5, 2025 - 10 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email
In Depth 4 Nov 2025 The biggest biotech funding rounds in October 2025 The companies Kailera Therapeutics, Summit Therapeutics, and Tubulis bagged the biggest biotech funding rounds overall in October 2025. November 4, 2025 - 5 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email